Protein kinase Cχ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation

Biochemical Journal

Volumn 473, Issue 4, 2016, Pages 509-523

  Tobias, Irene S ^a   Kaulich, Manuel ^b   Kim, Peter K ^c   Simon, Nitya ^a   Jacinto, Estela ^c   Dowdy, Steven F ^b   King, Charles C ^d   Newton, Alexandra C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Atypical protein kinase C; Insulin; MTOR complex; Phosphatidylinositol signalling; Phosphatidylserine; Phosphorylation

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PLECKSTRIN; PROTEIN KINASE B; PROTEIN KINASE C ZETA; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; MULTIPROTEIN COMPLEX; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; PROTEIN KINASE C; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; AMINO ACID SEQUENCE; ANIMAL; BIOCATALYSIS; CELL CULTURE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN CONFORMATION; TRANSGENIC MOUSE;

3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES; AMINO ACID SEQUENCE; ANIMALS; BIOCATALYSIS; CELLS, CULTURED; INSULIN; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN KINASE C; TOR SERINE-THREONINE KINASES;

EID: 84958525228     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20151013     Document Type: Article

References (91)

1. Farese, R.V., Sajan, M.P. and Standaert, M.L. (2005) Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp. Biol. Med. 230, 593-605
2. Farese, R.V. and Sajan, M.P. (2012) Atypical protein kinase C in cardiometabolic abnormalities. Curr. Opin. Lipidol. 23, 175-181
3. Farese, R.V. (2002) Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am. J. Physiol. Endocrinol. Metabol. 283, E1-E11
4. Bandyopadhyay, G., Standaert, M.L., Zhao, L., Yu, B., Avignon, A., Galloway, L., Karnam, P., Moscat, J. and Farese, R.V. (1997) Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J. Biol. Chem. 272, 2551-2558
5. Bandyopadhyay, G., Standaert, M.L., Galloway, L., Moscat, J. and Farese, R.V. (1997) Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138, 4721-4731
6. Standaert, M.L., Bandyopadhyay, G., Perez, L., Price, D., Galloway, L., Poklepovic, A., Sajan, M.P., Cenni, V., Sirri, A., Moscat, J. et al. (1999) Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J. Biol. Chem. 274, 25308-25316
7. Bandyopadhyay, G., Sajan, M.P., Kanoh, Y., Standaert, M.L., Quon, M.J., Lea-Currie, R., Sen, A. and Farese, R.V. (2002) PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J. Clin. Endocrinol. Metab. 87, 716-723
8. Bandyopadhyay, G., Standaert, M.L., Kikkawa, U., Ono, Y., Moscat, J. and Farese, R.V. (1999) Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda. Biochem. J. 337 (Pt 3), 461-470
9. Bandyopadhyay, G., Kanoh, Y., Sajan, M.P., Standaert, M.L. and Farese, R.V. (2000) Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes. Endocrinology 141, 4120-4127
10. Bandyopadhyay, G., Standaert, M.L., Sajan, M.P., Kanoh, Y., Miura, A., Braun, U., Kruse, F., Leitges, M. and Farese, R.V. (2004) Protein kinase C-lambda knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport. Mol. Endocrinol. 18, 373-383
11. Farese, R.V., Sajan, M.P., Yang, H., Li, P., Mastorides, S., Gower, Jr, W.R., Nimal, S., Choi, C.S., Kim, S., Shulman, G.I. et al. (2007) Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J. Clin. Invest. 117, 2289-2301
12. Beeson, M., Sajan, M.P., Dizon, M., Grebenev, D., Gomez-Daspet, J., Miura, A., Kanoh, Y., Powe, J., Bandyopadhyay, G., Standaert, M.L. and Farese, R.V. (2003) Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52, 1926-1934
13. Kim, Y.B., Kotani, K., Ciaraldi, T.P., Henry, R.R. and Kahn, B.B. (2003) Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes 52, 1935-1942
14. Sajan, M.P., Standaert, M.L., Miura, A., Bandyopadhyay, G., Vollenweider, P., Franklin, D.M., Lea-Currie, R. and Farese, R.V. (2004) Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects. J. Clin. Endocrinol. Metab. 89, 3994-3998
15. Standaert, M.L., Sajan, M.P., Miura, A., Kanoh, Y., Chen, H.C., Farese, Jr, R.V. and Farese, R.V. (2004) Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J. Biol. Chem. 279, 24929-24934
16. Sajan, M.P. and Farese, R.V. (2012) Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-iota (PKC-iota) and dependent processes and reversal by PKC-iota inhibitors. Diabetologia 55, 1446-1457
17. Sajan, M.P., Standaert, M.L., Rivas, J., Miura, A., Kanoh, Y., Soto, J., Taniguchi, C.M., Kahn, C.R. and Farese, R.V. (2009) Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance. Diabetologia 52, 1197-1207
18. Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R. et al. (2003) PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112, 935-944
19. Pu, Y., Peach, M.L., Garfield, S.H., Wincovitch, S., Marquez, V.E. and Blumberg, P.M. (2006) Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms. J. Biol. Chem. 281, 33773-33788
20. Kazanietz, M.G., Bustelo, X.R., Barbacid, M., Kolch, W., Mischak, H., Wong, G., Pettit, G.R., Bruns, J.D. and Blumberg, P.M. (1994) Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. J. Biol. Chem. 269, 11590-11594
21. Newton, A.C. (2001) Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101, 2353-2364
22. Newton, A.C. (2010) Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 298, E395-E402
23. Graybill, C., Wee, B., Atwood, S.X. and Prehoda, K.E. (2012) Partitioning-defective protein 6 (Par-6) activates atypical protein kinase C (aPKC) by pseudosubstrate displacement. J. Biol. Chem. 287, 21003-21011
24. Tsai, L.C., Xie, L., Dore, K., Xie, L., Del Rio, J.C., King, C.C., Martinez-Ariza, G., Hulme, C., Malinow, R., Bourne, P.E. et al. (2015) Zeta inhibitory peptide disrupts electrostatic interactions that maintain atypical protein kinase C in its active conformation on the scaffold p62. J. Biol. Chem. 290, 21845-21856
25. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934
26. Gao, T., Furnari, F. and Newton, A.C. (2005) PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell. 18, 13-24
27. Gao, T., Brognard, J. and Newton, A.C. (2008) The phosphatase PHLPP controls the cellular levels of protein kinase C. J. Biol. Chem. 283, 6300-6311
28. Edwards, A.S. and Newton, A.C. (1997) Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C. J. Biol. Chem. 272, 18382-18390
29. Bornancin, F. and Parker, P.J. (1997) Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J. Biol. Chem. 272, 3544-3549
30. Dutil, E.M., Toker, A. and Newton, A.C. (1998) Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8, 1366-1375
31. Le Good, J.A., Ziegler, W.H., Parekh, D.B., Alessi, D.R., Cohen, P. and Parker, P.J. (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042-2045
32. Chou, M.M., Hou, W., Johnson, J., Graham, L.K., Lee, M.H., Chen, C.S., Newton, A.C., Schaffhausen, B.S. and Toker, A. (1998) Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 8, 1069-1077
33. Dutil, E.M., Keranen, L.M., DePaoli-Roach, A.A. and Newton, A.C. (1994) In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J. Biol. Chem. 269, 29359-29362
34. Bandyopadhyay, G., Standaert, M.L., Sajan, M.P., Karnitz, L.M., Cong, L., Quon, M.J. and Farese, R.V. (1999) Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta. Mol. Endocrinol. 13, 1766-1772
35. Standaert, M.L., Bandyopadhyay, G., Kanoh, Y., Sajan, M.P. and Farese, R.V. (2001) Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. Biochemistry 40, 249-255
36. Hirai, T. and Chida, K. (2003) Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J. Biochem. 133, 1-7
37. Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B.A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551
38. Alessi, D.R., James, S.R., Downes, C.P., Holmes, A.B., Gaffney, P.R., Reese, C.B. and Cohen, P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7, 261-269
39. Li, X. and Gao, T. (2014) mTORC2 phosphorylates protein kinase Czeta to regulate its stability and activity. EMBO Rep. 15, 191-198
40. Chen, W., Goff, M.R., Kuang, H. and Chen, G. (2015) Higher protein kinase C zeta in fatty rat liver and its effect on insulin actions in primary hepatocytes. PloS One 10, e0121890
41. Frosig, C., Sajan, M.P., Maarbjerg, S.J., Brandt, N., Roepstorff, C., Wojtaszewski, J.F., Kiens, B., Farese, R.V. and Richter, E.A. (2007) Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle. J. Physiol. 582 Pt 3, 1289-1301
42. Hauge, C., Antal, T.L., Hirschberg, D., Doehn, U., Thorup, K., Idrissova, L., Hansen, K., Jensen, O.N., Jørgensen, T.J., Biondi, R.M. and Frödin, M. (2007) Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation. EMBO J. 26, 2251-2261
43. Bornancin, F. and Parker, P.J. (1996) Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Calpha. Curr. Biol. 6, 1114-1123
44. Edwards, A.S., Faux, M.C., Scott, J.D. and Newton, A.C. (1999) Carboxyl-terminal phosphorylation regulates the function and subcellular localization of protein kinase C betaII. J. Biol. Chem. 274, 6461-6468
45. Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C., Lowry, C., Newton, A.C., Mao, Y., Miao, R.Q. et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932-1943
46. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K.L. (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931
47. Oh, W.J., Wu, C.C., Kim, S.J., Facchinetti, V., Julien, L.A., Finlan, M., Roux, P.P., Su, B. and Jacinto, E. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 29, 3939-3951
48. Zinzalla, V., Stracka, D., Oppliger, W. and Hall, M.N. (2011) Activation of mTORC2 by association with the ribosome. Cell. 144, 757-768
49. Borner, C., Filipuzzi, I., Wartmann, M., Eppenberger, U. and Fabbro, D. (1989) Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J. Biol. Chem. 264, 13902-13909
50. Dutil, E.M. and Newton, A.C. (2000) Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol. J. Biol. Chem. 275, 10697-10701
51. Guertin, D.A., Stevens, D.M., Thoreen, C.C., Burds, A.A., Kalaany, N.Y., Moffat, J., Brown, M., Fitzgerald, K.J. and Sabatini, D.M. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell. 11, 859-871
52. Behn-Krappa, A. and Newton, A.C. (1999) The hydrophobic phosphorylation motif of conventional protein kinase C is regulated by autophosphorylation. Curr. Biol. 9, 728-737
53. Violin, J.D., Zhang, J., Tsien, R.Y. and Newton, A.C. (2003) A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J. Cell Biol. 161, 899-909
54. Kunkel, M.T., Ni, Q., Tsien, R.Y., Zhang, J. and Newton, A.C. (2005) Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J. Biol. Chem. 280, 5581-5587
55. Ezhevsky, S.A., Ho, A., Becker-Hapak, M., Davis, P.K. and Dowdy, S.F. (2001) Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol. Cell. Biol. 21, 4773-4784
56. Wu-Zhang, A.X., Murphy, A.N., Bachman, M. and Newton, A.C. (2012) Isozyme-specific interaction of protein kinase Cdelta with mitochondria dissected using live cell fluorescence imaging. J. Biol. Chem. 287, 37891-37906
57. Johnson, J.E., Edwards, A.S. and Newton, A.C. (1997) A putative phosphatidylserine binding motif is not involved in the lipid regulation of protein kinase C. J. Biol. Chem. 272, 30787-30792
58. Taylor, S.S., Shaw, A., Hu, J., Meharena, H.S. and Kornev, A. (2013) Pseudokinases from a structural perspective. Biochem. Soc. Trans. 41, 981-986
59. Johnson, J.E., Giorgione, J. and Newton, A.C. (2000) The C1 and C2 domains of protein kinase C are independent membrane targeting modules, with specificity for phosphatidylserine conferred by the C1 domain. Biochemistry 39, 11360-11369
60. Orr, J.W. and Newton, A.C. (1992) Interaction of protein kinase C with phosphatidylserine. 2. Specificity and regulation. Biochemistry 31, 4667-4673
61. Orr, J.W. and Newton, A.C. (1992) Interaction of protein kinase C with phosphatidylserine. 1. Cooperativity in lipid binding. Biochemistry 31, 4661-4667
62. Bell, R.M., Hannun, Y. and Loomis, C. (1986) Mixed micelle assay of protein kinase C. Methods Enzymol. 124, 353-359
63. Hannun, Y.A., Loomis, C.R. and Bell, R.M. (1986) Protein kinase C activation in mixed micelles. Mechanistic implications of phospholipid, diacylglycerol, and calcium interdependencies. J. Biol. Chem. 261, 7184-7190
64. Newton, A.C. and Koshland, Jr, D.E. (1990) Phosphatidylserine affects specificity of protein kinase C substrate phosphorylation and autophosphorylation. Biochemistry 29, 6656-6661
65. Sabatini, D.M. (2006) mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6, 729-734
66. Pearson, R.B., Dennis, P.B., Han, J.W., Williamson, N.A., Kozma, S.C., Wettenhall, R.E. and Thomas, G. (1995) The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14, 5279-5287
67. Wu-Zhang, A.X., Schramm, C.L., Nabavi, S., Malinow, R. and Newton, A.C. (2012) Cellular pharmacology of protein kinase Mzeta (PKMzeta) contrasts with its in vitro profile: implications for PKMzeta as a mediator of memory. J. Biol. Chem. 287, 12879-12885
68. Standaert, M.L., Galloway, L., Karnam, P., Bandyopadhyay, G., Moscat, J. and Farese, R.V. (1997) Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272, 30075-30082
69. Akimoto, K., Takahashi, R., Moriya, S., Nishioka, N., Takayanagi, J., Kimura, K., Fukui, Y., Osada, S.i., Mizuno, K., Hirai, S.i. et al. (1996) EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J. 15, 788-798
70. Antal, C.E., Violin, J.D., Kunkel, M.T., Skovso, S. and Newton, A.C. (2014) Intramolecular conformational changes optimize protein kinase C signaling. Chem. Biol. 21, 459-469
71. Andjelkovic, M., Alessi, D.R., Meier, R., Fernandez, A., Lamb, N.J., Frech, M., Cron, P., Cohen, P., Lucocq, J.M. and Hemmings, B.A. (1997) Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272, 31515-31524
72. Bellacosa, A., Chan, T.O., Ahmed, N.N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J. and Tsichlis, P. (1998) Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313-325
73. Trujillo, J.I., Kiefer, J.R., Huang, W., Thorarensen, A., Xing, L., Caspers, N.L., Day, J.E., Mathis, K.J., Kretzmer, K.K., Reitz, B.A. et al. (2009) 2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitor. Bioorg. Med. Chem. Lett. 19, 908-911
74. Kelly, M.T., Crary, J.F. and Sacktor, T.C. (2007) Regulation of protein kinase Mzeta synthesis by multiple kinases in long-term potentiation. J. Neurosci. 27, 3439-3444
75. Smith, L., Wang, Z. and Smith, J.B. (2003) Caspase processing activates atypical protein kinase C zeta by relieving autoinhibition and destabilizes the protein. Biochem. J. 375 Pt 3, 663-671
76. Ivey, R.A., Sajan, M.P. and Farese, R.V. (2014) Requirements for pseudosubstrate arginine residues during auto-inhibition and phosphatidylinositol-3,4,5-(PO4)3-dependent activation of atypical PKC. J. Biol. Chem. 289, 25021-25030
77. Lopez-Garcia, L.A., Schulze, J.O., Frohner, W., Zhang, H., Suss, E., Weber, N., Navratil, J., Amon, S., Hindie, V., Zeuzem, S. et al. (2011) Allosteric regulation of protein kinase PKCzeta by the N-terminal C1 domain and small compounds to the PIF-pocket. Chem. Biol. 18, 1463-1473
78. Nakanishi, H. and Exton, J.H. (1992) Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. J. Biol. Chem. 267, 16347-16354
79. Limatola, C., Schaap, D., Moolenaar, W.H. and van Blitterswijk, W.J. (1994) Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem. J. 304 Pt 3, 1001-1008
80. Cho, H., Mu, J., Kim, J.K., Thorvaldsen, J.L., Chu, Q., Crenshaw, 3rd, E.B., Kaestner, K.H., Bartolomei, M.S., Shulman, G.I. and Birnbaum, M.J. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728-1731
81. Braiman, L., Alt, A., Kuroki, T., Ohba, M., Bak, A., Tennenbaum, T. and Sampson, S.R. (2001) Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle. Mol. Cell. Biol. 21, 7852-7861
82. Kotani, K., Ogawa, W., Matsumoto, M., Kitamura, T., Sakaue, H., Hino, Y., Miyake, K., Sano, W., Akimoto, K., Ohno, S. and Kasuga, M. (1998) Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell. Biol. 18, 6971-6982
83. Imamura, T., Huang, J., Usui, I., Satoh, H., Bever, J. and Olefsky, J.M. (2003) Insulin-induced GLUT4 translocation involves protein kinase C-lambda-mediated functional coupling between Rab4 and the motor protein kinesin. Mol. Cell. Biol. 23, 4892-4900
84. Imamura, T., Ishibashi, K., Dalle, S., Ugi, S. and Olefsky, J.M. (1999) Endothelin-1-induced GLUT4 translocation is mediated via Galpha(q/11) protein and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem. 274, 33691-33695
85. Tsuru, M., Katagiri, H., Asano, T., Yamada, T., Ohno, S., Ogihara, T. and Oka, Y. (2002) Role of PKC isoforms in glucose transport in 3T3-L1 adipocytes: insignificance of atypical PKC. Am. J. Physiol. Endocrinol. Metab. 283, E338-E345
86. Hung, T.J. and Kemphues, K.J. (1999) PAR-6 is a conserved PDZ domain-containing protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos. Development 126, 127-135
87. Izumi, Y., Hirose, T., Tamai, Y., Hirai, S., Nagashima, Y., Fujimoto, T., Tabuse, Y., Kemphues, K.J. and Ohno, S. (1998) An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J. Cell Biol. 143, 95-106
88. Joberty, G., Petersen, C., Gao, L. and Macara, I.G. (2000) The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat. Cell Biol. 2, 531-539
89. Plant, P.J., Fawcett, J.P., Lin, D.C., Holdorf, A.D., Binns, K., Kulkarni, S. and Pawson, T. (2003) A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat. Cell Biol. 5, 301-308
90. Yamanaka, T., Horikoshi, Y., Sugiyama, Y., Ishiyama, C., Suzuki, A., Hirose, T., Iwamatsu, A., Shinohara, A. and Ohno, S. (2003) Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr. Biol. 13, 734-743
91. Toker, A. and Newton, A.C. (2000) Cellular signaling: pivoting around PDK-1. Cell. 103, 185-188